The abstract is read at the publisher; the summary is JClub's.
Single-cell RNA sequencing of bronchoalveolar lavage CD4+ T cells from beryllium-exposed patients (n=2) shows increased activation and immune-regulation gene expression, including IFNG and TNF.
- Why it matters: Chronic beryllium disease involves pathogenic CD4+ T cell accumulation in lungs, but early molecular biomarkers and therapeutic targets remain unclear.
- What they did: Sorted viable BAL cells were profiled by scRNA-seq in beryllium-exposed patients (n=2) and compared with healthy controls (n=10) from public scRNA-seq datasets, identifying 11 CD3-associated clusters.
- The result: CD4+ T cells from beryllium samples show upregulated activation/immune effector pathways and downregulated metabolic pathways, with distinct signatures including IFI27 and FABP4 for biomarker and target follow-up.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.